Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
DWDogwood Therapeutics, Inc. logo

Dogwood Therapeutics, Inc. (DWTX)

NASDAQ Capital Market · Currency in USD
$1.12 ▲ +0.00 (+0.00%)
At close: Oct 23, 4:00 PM ET. Market closed.
$1.22 ▲ +0.10 (+8.90%)
Pre-market: Oct 26, 7:07 AM ET

Summary

Previous Close
$1.12
Open
$1.15
Day's Range
$1.12 – $1.20
52 Week Range
$1.10 – $7.04
Volume
24,570
Avg. Volume
76,798
Market Cap
$38.07M
Beta (5Y Monthly)
1.94
PE Ratio (TTM)
--
EPS (TTM)
-$1.06
Earnings Date
Nov 5, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Dogwood Therapeutics, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
8
CEO
Gregory Duncan
Website
dwtx.com

Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to creating innovative antiviral treatments. Their primary goal is to address illnesses that stem from atypical immune reactions provoked by viral infections. Its leading therapeutic candidate, IMC-1, is a precise fixed-dose combination of famciclovir and celecoxib, engineered to combat fibromyalgia.

Earnings

Next report: Thu, Nov 5, 2026
EPS estimate -$0.15
DateEst.Actual
Aug 13, 2026-$0.14-$0.34Miss
May 14, 2026-$0.22-$0.15Beat
Mar 18, 2026-$0.86-$0.26Beat
Nov 6, 2025-$1.23-$8.20Miss
Aug 13, 2025-$1.26-$1.99Miss
May 8, 2025-$0.77-$8.45Miss

Analyst view

Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on DWTX and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.